Table 6.
Baseline characteristics of potentially relapsing patients
| Authors, year of publication | Patient’s status | Age (years) | Sex | Probable origin of infection | Chemoprophylaxis | Parasitaemia (parasites/µl) |
|---|---|---|---|---|---|---|
| Bottieau [28], 2005 | T | 17 | M | Ghana | Mefloquine | – |
| T | 22 | M | Nigeria | Mefloquine | – | |
| T | 14 | M | Uganda | None | – | |
| Collins et al. [29], 2002 | I | – | – | NA | NA | 3780 |
| I | – | – | NA | NA | 2220 | |
| I | – | – | NA | NA | 8560 | |
| I | – | – | NA | NA | 9810 | |
| I | – | – | NA | NA | 5376 | |
| Nathwani et al. [30], 1991 | T | 24 | M | Papua New Guinea | Chloroquine, pyrimethamine | – |
| Chin et al. [31], 1971 | E | – | M | NA | NA | – |
| E | – | M | NA | NA | – | |
| E | – | M | NA | NA | – | |
| E | – | M | NA | NA | – | |
| E | – | M | NA | NA | – | |
| Garnham et al. [32], 1955 | I | – | – | NA | NA | – |
| I | – | – | NA | NA | – | |
| Jeffery [33], 1954 | I | – | – | NA | NA | – |
| I | – | – | NA | NA | – |
T tourist, E sporozoite induced experimental infection, I malaria infection therapy in neurosyphilis patients, M male, F female, NA not applicable, – not mentioned in the original publication